Cancer-induced bone loss and associated pain-related behavior is reduced by risedronate but not its phosphonocarboxylate analog NE-10790. (Q46010704)
Jump to navigation
Jump to search
scientific article published in September 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cancer-induced bone loss and associated pain-related behavior is reduced by risedronate but not its phosphonocarboxylate analog NE-10790. |
scientific article published in September 2009 |
Statements
1 reference
Cancer-induced bone loss and associated pain-related behavior is reduced by risedronate but not its phosphonocarboxylate analog NE-10790. (English)
1 reference
1 reference
Andreas Hald
1 reference
Rikke R Hansen
1 reference
Mette W Thomsen
1 reference
Peter I Croucher
1 reference
Orla Gallagher
1 reference
Frank H Ebetino
1 reference
1 September 2009
1 reference
125
1 reference
5
1 reference
1177-1185
1 reference
Identifiers
1 reference
1 reference